Similar Papers

Paper Title
Journal
Date
Author
Incomplete Data in Clinical Studies: Analysis, Sensitivity, and Sensitivity Analysis
Geert Molenberghs
Drug Information Journal | VOL. 43
Geert MolenberghsGeert Molenberghs
01 Jul 2009
Comment: Incomplete Data in Clinical Studies: Analysis, Sensitivity, and Sensitivity Analysis
Joseph G Ibrahim
Drug Information Journal | VOL. 43
Joseph G IbrahimJoseph G Ibrahim
01 Jul 2009
The effect of organ at risk volume on the ability of IMRT plans to meet dosimetric criteria of the NCIIMRT benchmark and clinical studies
M Engler ... M Rivard
International Journal of Radiation OncologyBiologyPhysics | VOL. 60
M Engler, et. al.M Engler ... M Rivard
01 Sep 2004
RImmPort
Ravi D Shankar ... Sanchita Bhattacharya
-
Ravi D Shankar, et. al.Ravi D Shankar ... Sanchita Bhattacharya
20 Sep 2014
View more papers

More From: Drug Information Journal

Paper Title
Journal
Date
Author
Evaluating the Content of Advertisements for Dietary Supplements in Malaysian Women’s Magazines
Mohamed Azmi Hassali ... Fahad Saleem
Drug Information Journal | VOL. 46
Mohamed Azmi Hassali, et. al.Mohamed Azmi Hassali ... Fahad Saleem
01 Nov 2012
Review of Pharmaceutical Competitive Intelligence for the Regulatory Affairs Professional
Edward Tabor
Drug Information Journal | VOL. 46
Edward TaborEdward Tabor
01 Nov 2012
A Statistical Framework for Decision Making in Confirmatory Multipopulation Tailoring Clinical Trials
Brian A Millen ... Lei Shen
Drug Information Journal | VOL. 46
Brian A Millen, et. al.Brian A Millen ... Lei Shen
01 Nov 2012
Adverse Reaction Signaling and Disproportionality Analysis: An Update
Gerald Faich ... Jonathan Morris
Drug Information Journal | VOL. 46
Gerald Faich, et. al.Gerald Faich ... Jonathan Morris
01 Nov 2012
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.